Systematic review of the accuracy of antibody tests used to screen asymptomatic adults for hepatitis C infection
- PMID: 28018889
- PMCID: PMC5173481
- DOI: 10.9778/cmajo.20160084
Systematic review of the accuracy of antibody tests used to screen asymptomatic adults for hepatitis C infection
Abstract
Background: Several expert groups, including the United States Preventive Services Task Force and the Canadian Task Force on Preventive Health Care, have recently examined or are currently examining whether primary care physicians should screen asymptomatic adults for hepatitis C virus (HCV) infection. To inform decision-making on HCV screening, we performed a systematic review of the accuracy of antibody tests compared with other immunoassays and RNA detection for screening asymptomatic adults for HCV infection in Canada.
Methods: MEDLINE and Embase databases were searched from 1990 to 2016; resulting citations were uploaded into DistillerSR and independently screened by 2 reviewers. Original research studies, systematic reviews and meta-analyses were eligible for inclusion. At least 80% of the study population had to be asymptomatic, nonpregnant, treatment-naïve adults with unknown liver enzyme values and unknown HCV status. Risk of bias was assessed with the use of the Quality Assessment of Diagnostic Accuracy Studies version 2 (QUADAS-2) tool; the quality of the body of evidence was assessed by means of GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology.
Results: Of 1537 articles identified, 81 underwent full-text review, and 9 studies met the inclusion criteria. Compared with RNA detection, the sensitivity of the third-generation enzyme-linked immunosorbent assay was variable (61.0%-81.8%), and its specificity was high (97.5%-99.7%). As expected, there were more false-positive results when comparing antibody tests to RNA detection than to other immunoassays. Our GRADE assessment suggested that there was a high concern for risk of bias, particularly verification bias, and substantial inconsistency between studies in terms of their design.
Interpretation: More research is needed to better characterize the accuracy of antibody tests used to screen for HCV infection in the general population. Jurisdictions that recently adopted birth cohort screening for HCV infection are encouraged to evaluate and report on the accuracy of HCV screening tests and screening benefits and harms. PROSPERO registration: no. CRD42016039710.
Conflict of interest statement
Conflicts of Interest: None declared.
Figures
References
-
- Hepatitis C in Canada: 2005-2010 surveillance report. Ottawa: Public Health Agency of Canada. 2012. [accessed 2016 Mar. 29]. Available http://publications.gc.ca/collections/collection_2012/aspc-phac/HP40-70-....
-
- Chou R, Cottrell EB, Wasson N, et al. Screening for hepatitis C virus infection in adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013;158:101–8. - PubMed
-
- Provincial Infectious Diseases Advisory Committee on Communicable Diseases, Ontario Agency for Health Protection and Promotion (Public Health Ontario). Recommendations for the public health response to hepatitis C in Ontario. Toronto: Queen's Printer for Ontario. 2014. [accessed 2016 May 9]. Available www.publichealthontario.ca/en/eRepository/Recommendations_Public_Health_....
-
- Hepatitis C: essential information for professionals and guidance on testing. London (UK): National Health Service. 2004. [accessed 2016 Mar. 24]. Available www.nhs.uk/hepatitisc/SiteCollectionDocuments/pdf/essential-information-....
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous